Skip to content
Health · Brazil

Anvisa considered the immunogenicity data for Coronavac inadequate

Machine-translated from Portuguese. Original: Anvisa considerou dado de imunogenicidade da Coronavac inadequado

Is it true?

Misleadingaccording to Comprova

Comprova checked this claim on 22 January 2021.

“ENGANOSO: Dirigente da Anvisa disse, de fato, que dados de imunogenicidade - a capacidade que uma vacina tem para induzir o sistema imunológico a produzir anticorpos - da CoronaVac eram inadequados. A Anvisa explicou, no entanto, que não há questionamentos em relação à segurança da vacina.”

  1. Português

    Read the fact-check at Comprova

Related

NamesBrazilian Health Regulatory Agency

Something wrong here? Report it by emailinfo@factiz.org

The verdict belongs to the newsroom: report an error in it to them, through their article above. Report an error in what Factiz added, such as the translation, the theme or the names, to us.

Record from: Data Commons (ClaimReview feed), with the fact-check of the newsroom named. Licence: CC BY 4.0. Factiz added the language, the verdict category and the grouping of the same claim.

The sources are the verdict.